We used this strategy to identify a naturally sourced small molecule, DP, which inhibits NLRP3 inflammasome activation via CMPK2 and, thus, is a potential treatment for inflammasome‐associated diseases such as sepsis. Here, NLRP3 is linked to Sepsis.